Found 12 articles for: "Squamous Cell Carcinoma"

Clinical Features and the Management of Drug-Induced Eruptive Keratoacanthoma and Squamous Cell Carcinoma: A Review of 172 Cases

May 2025 | Volume 24 | Issue 5 | | 476 | Copyright © May 2025

Squamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery

May 2025 | Volume 24 | Issue 5 | Original Article | 494 | Copyright © May 2025

Synergistic Mechanisms of 5-Fluorouracil and Imiquimod in the Treatment of Actinic Keratoses

May 2025 | Volume 24 | Issue 5 | | e35 | Copyright © May 2025

Citation: Regester RM, Cannella AC, Thiele GM, et al. Synergistic mechanisms of 5-fluorouracil and imiquimod in the treatment of actinic keratoses. J Drugs Dermatol. 2025;24(5):e35....
Read More

Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report

February 2024 | Volume 23 | Issue 2 | | 54 | Copyright © February 2024

Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine and Discussion of Treatment

May 2023 | Volume 22 | Issue 5 | Case Reports | 509 | Copyright © May 2023

Shah M, Wald J, Hanke CW. Eruptive Squamous cell carcinomas following treatment with fludarabine and discussion of treatment. J Drugs Dermatol. 2023;22(5):509-510....
Read More

Dilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series

May 2023 | Volume 22 | Issue 5 | Case Reports | 507 | Copyright © May 2023

Non-Invasive Diagnosis of Sun Damaged Skin: Actinic Keratosis Vs Squamous Cell Carcinoma

May 2023 | Volume 22 | Issue 5 | | 440 | Copyright © May 2023

Treatment of Reactive Keratoacanthomas with Acitretin Following Multiple Excisions and Mohs Surgery for Recurrent Squamous Cell Carcinoma

December 2022 | Volume 21 | Issue 12 | Case Reports | 1353 | Copyright © December 2022

Surgical intervention is seen as the gold standard in the treatment of Squamous cell carcinoma. Yet, in cases of recurrence, repeated surgical procedures may unwittingly foment the rise of reactive ke...
Read More

Safety and Efficacy of TGF-β1/COX-2 Silencing Therapeutic in Adults With Cutaneous Squamous Cell Carcinoma In Situ

May 2022 | Volume 21 | Issue 5 | | 472 | Copyright © May 2022

This single-center, open label, dose escalation cohort study evaluated the safety and efficacy of various doses of intralesional injections of TGF-Read More

Dermoscopy and Reflectance Confocal Microscopy in Actinic Keratosis, Intraepithelial Carcinoma, and Invasive Squamous Cell Carcinoma

March 2022 | Volume 21 | Issue 3 | | 259 | Copyright © March 2022

Background: Patients with multiple actinic keratosis (AK), have pre-neosplastic abnormalities, constituting the sites of new tumors, this region is called the cancerization field. Due...
Read More

Combining Panitumumab With Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck After Inadequate Response to Anti-PD-1 Antibody Alone

August 2021 | Volume 20 | Issue 8 | Case Reports | 901 | Copyright © August 2021

Anti-epidermal growth factor receptor (EGFR) antibodies and anti-programmed cell death 1 protein (PD-1) antibodies have been used separately to treat metastatic cutaneous squamous cell carcinoma (cSCC...
Read More

Rapid Evolution of a Squamous Cell Carcinoma In Situ to Locally Invasive With Perineural Involvement

November 2020 | Volume 19 | Issue 11 | Case Reports | 1110 | Copyright © November 2020

We present a case of rapidly progressing squamous cell carcinoma in situ (SCCis) with progression to aggressive SCC. An elderly gentleman with multiple medical comorbidities presented with a left zygo...
Read More